Related Experiment Video
Updated: Jun 19, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Tuberculosis with a hemophagocytic syndrome]
J Sandrini1, A-B Beucher, M-C Rousselet
1Département de médecine interne et gérontologie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.
Medecine Et Maladies Infectieuses
|October 20, 2009
Summary
Hemophagocytic syndrome, a rare condition, can be linked to tuberculosis. This case highlights a favorable outcome with antibiotics and corticosteroids for a patient with recurrent pleuropneumonia and suspected hemophagocytic syndrome.
Area of Science:
- Internal Medicine
- Infectious Diseases
- Hematology
Background:
- Hemophagocytic syndrome (HPS) is a rare, life-threatening condition characterized by excessive immune activation.
- Tuberculosis (TB) is an opportunistic infection that can trigger HPS in immunocompromised individuals.
Observation:
- A 30-year-old migrant from Congo presented with recurrent right pleuropneumonia, cachexia, and night sweats.
- Diagnostic workup revealed bicytopenia, mediastinal lymphadenopathy, pleuritis, and granulomatous lymphadenopathy with necrosis.
- Bone marrow biopsy findings were suggestive of hemophagocytic syndrome.
Findings:
- The patient was diagnosed with hemophagocytic syndrome potentially secondary to an underlying infectious process, possibly tuberculosis given the clinical presentation and lymphadenopathy.
- Treatment with antibiotics and corticosteroids led to a favorable clinical outcome.
Implications:
- This case underscores the importance of considering HPS in patients with unexplained fever, cytopenias, and organomegaly, especially in endemic areas for tuberculosis.
- Early diagnosis and prompt treatment with antimicrobials and immunosuppressants can improve outcomes in HPS.
- Highlights the diagnostic challenges and management of HPS in resource-limited settings.
Related Concept Videos
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...